Paris, June 6, 2025 – Jeantet is advising Cureety in connection with its acquisition of the company Continuum Plus Santé, both specializing on remote monitoring for cancer patients.
Through this acquisition, Cureety consolidates its leadership position in remote monitoring in oncology, particularly through better management of the “Hospital-City-Home” care pathway by enabling the involvement of community pharmacists and private nurses alongside general practitioners, who are key players in the care of cancer patients, an area in which Continuum Plus Santé specializes.
The proposed transaction, for which exclusive negotiations were announced on May 21, 2025, remains subject to certain conditions precedent and is expected to be completed before the end of June 2025.
Download the press release





